Safety of ACE-I and ARB medications in COVID-19: A retrospective cohort study of inpatients and outpatients in California

INTRODUCTION: There is significant interest in the use of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARB) in coronavirus disease 2019 (COVID-19) and concern over potential adverse effects since these medications upregulate the severe acute respiratory synd...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, Samuel J. S., Falkson, Samuel R., Degner, Nicholas R., Blish, Catherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605244/
https://www.ncbi.nlm.nih.gov/pubmed/34611496
http://dx.doi.org/10.1017/cts.2020.489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605244/
https://www.ncbi.nlm.nih.gov/pubmed/34611496
http://dx.doi.org/10.1017/cts.2020.489

Ejemplares similares